PRL antibody
Ref. 3D-10R-5446
| 100µl | 1.084,00 € |
Información del producto
The PRL antibody is a monoclonal antibody known as trastuzumab. It is used in the treatment of certain types of cancer, particularly breast cancer that overexpresses the HER2 protein. This antibody works by binding to the HER2 receptors on cancer cells, inhibiting their growth and promoting cell death. In addition to its anti-cancer properties, trastuzumab has been shown to have other therapeutic effects. It can enhance the activity of lysozyme, an enzyme involved in immune defense, and stimulate tyrosine kinase receptors, which play a role in cell growth and development. Furthermore, trastuzumab has been found to inhibit insulin-like growth factor signaling and dopamine release, both of which are implicated in tumor progression. Overall, this monoclonal antibody offers targeted therapy for HER2-positive cancers and holds promise for improving patient outcomes.
Propiedades químicas
Consulta técnica sobre: 3D-10R-5446 PRL antibody
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
